Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

NCT02812342 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yale University